This is the first study indicating the abundancy of disease-relevant circulating circRNAs in HCM and highlighting the importance of a set of circRNAs as possible novel indicators of HCM.
Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy.